-
1
-
-
0028887981
-
End of the New Zealand asthma mortality epidemic
-
Pearce N, Beasley R, Crane J, Burgess C, Jackson R. End of the New Zealand asthma mortality epidemic [see comments]. Lancet 1995; 345:41-4.
-
(1995)
Lancet
, vol.345
, pp. 41-44
-
-
Pearce, N.1
Beasley, R.2
Crane, J.3
Burgess, C.4
Jackson, R.5
-
2
-
-
0028264310
-
Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group
-
Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group. Lancet 1994; 344: 219-24.
-
(1994)
Lancet
, vol.344
, pp. 219-224
-
-
Greening, A.P.1
Ind, P.W.2
Northfield, M.3
Shaw, G.4
-
3
-
-
0033585883
-
Clinical guidelines: Potential benefits, limitations, and harms of clinical guidelines
-
Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J. Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ 1999; 318: 527-30.
-
(1999)
BMJ
, vol.318
, pp. 527-530
-
-
Woolf, S.H.1
Grol, R.2
Hutchinson, A.3
Eccles, M.4
Grimshaw, J.5
-
4
-
-
0033583746
-
Users' guides to the medical literature: XVI. How to use a treatment recommendation. Evidence-Based Medicine Working Group and the Cochrane Applicability Methods Working Group
-
Guyatt GH, Sinclair J, Cook DJ, Glasziou P. Users' guides to the medical literature: XVI. How to use a treatment recommendation. Evidence-Based Medicine Working Group and the Cochrane Applicability Methods Working Group. JAMA 1999; 281: 1836-43.
-
(1999)
JAMA
, vol.281
, pp. 1836-1843
-
-
Guyatt, G.H.1
Sinclair, J.2
Cook, D.J.3
Glasziou, P.4
-
5
-
-
0032529297
-
Guidelines for clinical guidelines
-
Jackson R, Feder G. Guidelines for clinical guidelines [editorial]. BMJ 1998; 317: 427-8.
-
(1998)
BMJ
, vol.317
, pp. 427-428
-
-
Jackson, R.1
Feder, G.2
-
6
-
-
0342743084
-
-
Global strategy for asthma management and prevention. WHO/ NHLBI workshop report. National Institutes of Health, National Heart, Lung and Blood Institute, Publication Number 95-3659 1995
-
Global strategy for asthma management and prevention. WHO/ NHLBI workshop report. National Institutes of Health, National Heart, Lung and Blood Institute, Publication Number 95-3659 1995.
-
-
-
-
7
-
-
0031912740
-
Airway inflammation in mild intermittent and in persistant asthma
-
Vignola AM, Chanez P, Campbell AM et al. Airway inflammation in mild intermittent and in persistant asthma. Am J Respir Crit Care Med 1998; 157:403-9.
-
(1998)
Am J Respir Crit Care Med
, vol.157
, pp. 403-409
-
-
Vignola, A.M.1
Chanez, P.2
Campbell, A.M.3
-
10
-
-
0032564163
-
House dust mite control measures in the management of asthma: Meta-analysis
-
Gotzsche PC, Hammarquist C, Burr M. House dust mite control measures in the management of asthma: meta-analysis. BMJ 1998; 317: 1105-10.
-
(1998)
BMJ
, vol.317
, pp. 1105-1110
-
-
Gotzsche, P.C.1
Hammarquist, C.2
Burr, M.3
-
11
-
-
0032564157
-
House dust mite allergen avoidance in asthma. Benefits unproved hut not yet excluded
-
Strachan DP. House dust mite allergen avoidance in asthma. Benefits unproved hut not yet excluded [editorial]. BMJ 1998; 317:1096-7.
-
(1998)
BMJ
, vol.317
, pp. 1096-1097
-
-
Strachan, D.P.1
-
12
-
-
0033608648
-
Control of house dust mite in managing asthma. Conclusions of meta-analysis are wrong
-
Platts-Mills TA, Chapman MD, Wheatly LM. Control of house dust mite in managing asthma. Conclusions of meta-analysis are wrong [letter; comment]. BMJ 1999; 318:870-1.
-
(1999)
BMJ
, vol.318
, pp. 870-871
-
-
Platts-Mills, T.A.1
Chapman, M.D.2
Wheatly, L.M.3
-
13
-
-
0343613032
-
Differences between asthma exacerbations and poor asthma control
-
9
-
Reddel H, Ware S, Marks G, Salome C, Jenkins C, Woolcock A. Differences between asthma exacerbations and poor asthma control. Lancet 1999; 553 (364-9): 14.
-
(1999)
Lancet
, vol.553
, Issue.364
, pp. 14
-
-
Reddel, H.1
Ware, S.2
Marks, G.3
Salome, C.4
Jenkins, C.5
Woolcock, A.6
|